KOL
KOL
Scientific Advisor and Regulatory Affairs Guidance.
Founder, Chairman and EVP of Partnerships and Investor Relations
Founder, CEO
BioCellgraft - BioCellgraft specializes in regenerative health therapies specifically designed to enhance soft and hard tissue regeneration within the oral cavity. Our flagship product, OraFyl, is a highly purified biological matrix derived from the chorionic portion of the human placenta (HPCTM - Human Placenta Connective Tissue Matrix). It consists of native collagen and elastin presented in their most purified molecular scaffold form.
BioCellgraft specializes in regenerative health therapies specifically designed to enhance soft and hard tissue regeneration within the oral cavity. Our flagship product, OraFyl, is a highly purified biological matrix derived from the chorionic portion of the human placenta (HPCTM - Human Placenta Connective Tissue Matrix). It consists of native collagen and elastin presented in their most purified molecular scaffold form.